CAS RN: 1714123-51-9

1H-Thieno[3,4-d]imidazole-4-pentanamide, hexahydro-2-oxo-N-[[4-(1,2,4,5-tetrazin-3-yl)phenyl]methyl]-, (3aS,4S,6aR)-

Product Availability

Choose a grade to view its available package options.

5 package records5 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260522 100mg In stock Shanghai Inquiry
Batchno.20260209 10mg In stock Shanghai Inquiry
Batchno.20250621 250mg In stock Shanghai Inquiry
Batchno.20250106 25mg In stock Shanghai Inquiry
Batchno.20250702 50mg In stock Shanghai Inquiry
  • Product code: starshine_CAS1714123-51-9
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1714123-51-9 / 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[[4-(1,2,4,5-tetrazin-3-yl)phenyl]methyl]pentanamide

Standard CAS: 1714123-51-9 Multi CAS: No

Basic Information

CAS
1714123-51-9
Multi CAS
No
Molecular Formula
C19H23N7O2S
Molecular Weight
413.500000
Exact Mass
413.163394
SMILES
C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCC3=CC=C(C=C3)C4=NN=CN=N4)NC(=O)N2
InChI
InChI=1S/C19H23N7O2S/c27-16(4-2-1-3-15-17-14(10-29-15)23-19(28)24-17)20-9-12-5-7-13(8-6-12)18-25-21-11-22-26-18/h5-8,11,14-15,17H,1-4,9-10H2,(H,20,27)(H2,23,24,28)/t14-,15-,17-/m0/s1
InChIKey
GBJXXSUDJUYIIH-ZOBUZTSGSA-N

Computed Properties

Structural Parameters

Heavy atom count
29
Aromatic heavy atom count
12
Fraction Csp3
0.47
Rotatable bonds
8
H-bond acceptors
7
H-bond donors
3
Molar refractivity
108.86
TPSA
121.79

LogP / Solubility

WLOGP
1.28
MLOGP
1.15
XLogP3
-0.1
Consensus LogP
0.78
Log S (ESOL)
-2.99
Class (ESOL)
Moderately soluble
Log S (Ali)
-3.87
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-4.37
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.34

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
4.5

Get In Touch

Contact Us